Treatment of Sarcoidosis with Lupus Pernio (Cutaneous Sarcoidosis)
This page addresses the first-line management of sarcoidosis in patients presenting with lupus pernio, a particular form of skin sarcoidosis that falls within the broader category of cutaneous sarcoidosis.
Clinical Scenario
The patient has cutaneous sarcoidosis with lupus pernio — a specific skin manifestation of sarcoidosis that warrants a targeted management approach. Evidence indicates that different therapeutic strategies carry meaningfully different outcomes in this particular presentation.
Treatment Approach
The first-line strategy for this scenario centres on systemic corticosteroid therapy. Because prolonged corticosteroid use carries a range of potential side effects, the complete protocol details how treatment is structured — including when and how to consider alternative agents. The full sequenced regimen is available via the link below.
References
- For lupus pernio, a large retrospective study reported that anti-TNF therapy was significantly better than cytotoxic or antimalarial therapy, and it could be considered as second-line therapy for this particular form of skin sarcoidosis.
- Systemic corticosteroids are usually used at least for the short term, but because of their many potential side effects, other agents should be considered for longer-term treatment.
View source ↗